Published in Addict Biol on March 07, 2008
Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice. PLoS One (2012) 0.78
ABC transporters P-gp and Bcrp do not limit the brain uptake of the novel antipsychotic and anticonvulsant drug cannabidiol in mice. PeerJ (2016) 0.78
Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning. Neuropsychopharmacology (2006) 1.90
Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol (2010) 1.71
New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol (2007) 1.70
Oseltamivir carboxylate accumulation in a patient treated by haemodiafiltration and extracorporeal membrane oxygenation. Intensive Care Med (2010) 1.44
Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine model. Antimicrob Agents Chemother (2010) 1.36
In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab Dispos (2003) 1.12
Population pharmacokinetics and bioavailability of tacrolimus in kidney transplant patients. Br J Clin Pharmacol (2007) 1.08
Understanding impulsivity in severe depression? A psychometrical contribution. Prog Neuropsychopharmacol Biol Psychiatry (2003) 1.07
GHB and synthetic cathinones: clinical effects and potential consequences. Drug Test Anal (2010) 1.06
Effect of efavirenz on intestinal p-glycoprotein and hepatic p450 function in rats. J Pharm Pharm Sci (2005) 1.04
Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence. Expert Rev Neurother (2008) 1.01
Sexual addiction or hypersexual disorder: different terms for the same problem? A review of the literature. Curr Pharm Des (2014) 1.01
Diffusion tensor tractography in mesencephalic bundles: relation to mental flexibility in detoxified alcohol-dependent subjects. Neuropsychopharmacology (2008) 1.00
Peer substance use overestimation among French university students: a cross-sectional survey. BMC Public Health (2010) 1.00
Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo. Eur J Pharmacol (2010) 0.99
Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model. Am J Obstet Gynecol (2006) 0.98
Pharmacological treatments for cocaine dependence: is there something new? Curr Pharm Des (2011) 0.96
Are social norms associated with smoking in French university students? A survey report on smoking correlates. Subst Abuse Treat Prev Policy (2009) 0.96
Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearance. Eur J Clin Pharmacol (2005) 0.96
Pharmacotherapy for smoking cessation: present and future. Curr Pharm Des (2011) 0.94
Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation. Antimicrob Agents Chemother (2008) 0.92
Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study. Clin Pharmacokinet (2007) 0.92
Comparison of ABC transporter modulation by atazanavir in lymphocytes and human brain endothelial cells: ABC transporters are involved in the atazanavir-limited passage across an in vitro human model of the blood-brain barrier. AIDS Res Hum Retroviruses (2008) 0.91
Minocycline and riluzole brain disposition: interactions with p-glycoprotein at the blood-brain barrier. J Neurochem (2007) 0.91
Brain and plasma riluzole pharmacokinetics: effect of minocycline combination. J Pharm Pharm Sci (2009) 0.91
Acute and long-term effects of cannabis use: a review. Curr Pharm Des (2014) 0.91
Current smoking, hypoxia, and suicide. Am J Psychiatry (2011) 0.91
Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. J Pharm Sci (2004) 0.91
Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model. Obstet Gynecol Int (2009) 0.90
Intestinal absorption of miltefosine: contribution of passive paracellular transport. Pharm Res (2007) 0.90
Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process. Lipids (2007) 0.90
Excessive indoor tanning as a behavioral addiction: a literature review. Curr Pharm Des (2014) 0.90
A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery. PLoS Comput Biol (2011) 0.90
Influence of tumor necrosis factor-alpha on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochem Pharmacol (2003) 0.90
Association between a polymorphism in the promoter of a glutamate receptor subunit gene (GRIN2A) and alcoholism. Addict Biol (2011) 0.89
ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier. J Alzheimers Dis (2012) 0.89
Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulation. J Biol Chem (2009) 0.88
Pathways to substance-related disorder: a structural model approach exploring the influence of temperament, character, and childhood adversity in a national cohort of prisoners. Alcohol Alcohol (2008) 0.88
Defense styles, impulsivity and suicide attempts in major depression. Psychopathology (2003) 0.88
P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis. Neurosci Lett (2010) 0.88
Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion. Int J Pharm (2003) 0.88
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol (2011) 0.87
Is baclofen a revolutionary medication in alcohol addiction management? Review and recent updates. Subst Abus (2012) 0.86
Interactions between riluzole and ABCG2/BCRP transporter. Neurosci Lett (2009) 0.86
Stability of oxaliplatin solution. Ann Pharmacother (2009) 0.86
Striatal and extrastriatal dopamine transporter in cannabis and tobacco addiction: a high-resolution PET study. Addict Biol (2011) 0.86
Long-term effect of leptin on H+-coupled peptide cotransporter 1 activity and expression in vivo: evidence in leptin-deficient mice. J Pharmacol Exp Ther (2007) 0.86
Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study. Subst Abuse Treat Prev Policy (2007) 0.85
Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza. Ther Drug Monit (2012) 0.85
[Energy drinks: an unknown risk]. Rev Prat (2012) 0.84
Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study). Antivir Ther (2004) 0.84
Chronic alcohol consumption and its effect on nodes of frontocerebellar and limbic circuitry: comparison of effects in France and the United States. Hum Brain Mapp (2014) 0.84
Is love passion an addictive disorder? Am J Drug Alcohol Abuse (2010) 0.84
Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.84
Imaging of language-related brain regions in detoxified alcoholics. Alcohol Clin Exp Res (2009) 0.84
Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier. Pharm Res (2006) 0.84
Population pharmacokinetics of everolimus in cardiac recipients: comedications, ABCB1, and CYP3A5 polymorphisms. Ther Drug Monit (2012) 0.83
Therapeutic efficiency of everolimus and lapatinib in xenograft model of human colorectal carcinoma with KRAS mutation. Fundam Clin Pharmacol (2012) 0.83
Bioavailability and tissular distribution of docetaxel, a P-glycoprotein substrate, are modified by interferon-alpha in rats. J Pharm Pharmacol (2007) 0.83
Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib. Clin Cancer Res (2005) 0.83
Heavy episodic drinking and alcohol consumption in French colleges: the role of perceived social norms. Alcohol Clin Exp Res (2009) 0.83
MDR-1 C3435T polymorphism influences cyclosporine a dose requirement in liver-transplant recipients. Transplantation (2004) 0.83
Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. Pharm Res (2008) 0.83
Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir. Eur J Obstet Gynecol Reprod Biol (2009) 0.82
Emtricitabine: Inhibitor and substrate of multidrug resistance associated protein. Eur J Pharm Sci (2008) 0.82
Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro. Antimicrob Agents Chemother (2006) 0.82
A damage/benefit evaluation of addictive product use. Addiction (2012) 0.82
Episodic memory in detoxified alcoholics: contribution of grey matter microstructure alteration. PLoS One (2009) 0.81
Intestinal inflammation induces adaptation of P-glycoprotein expression and activity. Biochem Pharmacol (2005) 0.81
Modulation of intestinal barrier properties by miltefosine. Biochem Pharmacol (2005) 0.81
Role of two efflux proteins, ABCB1 and ABCG2 in blood-brain barrier transport of bromocriptine in a murine model of MPTP-induced dopaminergic degeneration. J Pharm Pharm Sci (2009) 0.81
Self-mutilation induced by cocaine abuse: the pleasure of bleeding. Presse Med (2006) 0.81
Cannabis arteritis: review of the literature. J Addict Med (2010) 0.80
Protective effect against alcohol dependence of the thermolabile variant of MTHFR. Drug Alcohol Depend (2008) 0.80
Cyamemazine metabolites: effects on human cardiac ion channels in-vitro and on the QTc interval in guinea pigs. J Pharm Pharmacol (2008) 0.80
Drug addiction, love, and the higher power. Eval Health Prof (2011) 0.80
Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in mice. Anticancer Drugs (2010) 0.80
Cetuximab increases concentrations of irinotecan and of its active metabolite SN-38 in plasma and tumour of human colorectal carcinoma-bearing mice. Fundam Clin Pharmacol (2014) 0.79
Effect of interleukin-2 on intestinal P-glycoprotein expression and functionality in mice. J Pharmacol Exp Ther (2002) 0.79
Association between MTHFR 677C-T polymorphism and alcohol dependence according to Lesch and Babor typology. Addict Biol (2009) 0.79
[Management of comorbid bipolar disorder and alcohol dependence]. Presse Med (2008) 0.79
[Complications of cocaine addiction]. Rev Prat (2009) 0.79
Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patients. Eur J Drug Metab Pharmacokinet (2011) 0.79
[Validation of a questionnaire to screen for harmful use of alcohol and cannabis in the general population: CRAFFT-ADOSPA]. Presse Med (2007) 0.79
Rosiglitazone and metformin have opposite effects on intestinal absorption of oligopeptides via the proton-dependent PepT1 transporter. Mol Pharmacol (2011) 0.78